BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 10498899)

  • 1. Identification of the secretory leukocyte protease inhibitor (SLPI) as a target of IRF-1 regulation.
    Nguyen H; Teskey L; Lin R; Hiscott J
    Oncogene; 1999 Sep; 18(39):5455-63. PubMed ID: 10498899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon-gamma regulation of the human mimecan promoter.
    Tasheva ES; Conrad GW
    Mol Vis; 2003 Jun; 9():277-87. PubMed ID: 12835654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of the interferon regulatory factors, IRF-1 and IRF-2, in LPS-induced cyclooxygenase-2 (COX-2) expression in vivo and in vitro.
    Zhang S; Thomas K; Blanco JC; Salkowski CA; Vogel SN
    J Endotoxin Res; 2002; 8(5):379-88. PubMed ID: 12537697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcription factor IRF-2 exerts its oncogenic phenotype through the DNA binding/transcription repression domain.
    Nguyen H; Mustafa A; Hiscott J; Lin R
    Oncogene; 1995 Aug; 11(3):537-44. PubMed ID: 7630638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of the lysyl oxidase gene as target of the antioncogenic transcription factor, IRF-1, and its possible role in tumor suppression.
    Tan RS; Taniguchi T; Harada H
    Cancer Res; 1996 May; 56(10):2417-21. PubMed ID: 8625321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of multiple growth regulatory genes following inducible expression of IRF-1 or IRF/RelA fusion proteins.
    Nguyen H; Lin R; Hiscott J
    Oncogene; 1997 Sep; 15(12):1425-35. PubMed ID: 9333018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The interferon regulatory factors 1 and 2 bind to a segment of the human c-myb first intron: possible role in the regulation of c-myb expression.
    Manzella L; Gualdi R; Perrotti D; Nicolaides NC; Girlando G; Giuffrida MA; Messina A; Calabretta B
    Exp Cell Res; 2000 Apr; 256(1):248-56. PubMed ID: 10739671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumour necrosis factor-alpha and interferon-gamma synergistically activate the RANTES promoter through nuclear factor kappaB and interferon regulatory factor 1 (IRF-1) transcription factors.
    Lee AH; Hong JH; Seo YS
    Biochem J; 2000 Aug; 350 Pt 1(Pt 1):131-8. PubMed ID: 10926836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The oncogenic transcription factor IRF-2 possesses a transcriptional repression and a latent activation domain.
    Yamamoto H; Lamphier MS; Fujita T; Taniguchi T; Harada H
    Oncogene; 1994 May; 9(5):1423-8. PubMed ID: 8152803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of secretory leukoprotease inhibitor gene expression in human bronchial epithelial cells by phorbol ester.
    Maruyama M; Hay JG; Yoshimura K; Chu CS; Crystal RG
    J Clin Invest; 1994 Jul; 94(1):368-75. PubMed ID: 7913712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preferential binding sites for interferon regulatory factors 3 and 7 involved in interferon-A gene transcription.
    Morin P; Bragança J; Bandu MT; Lin R; Hiscott J; Doly J; Civas A
    J Mol Biol; 2002 Mar; 316(5):1009-22. PubMed ID: 11884139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The repressive function of AP2 transcription factor on the hepatocyte growth factor gene promoter.
    Jiang JG; DeFrances MC; Machen J; Johnson C; Zarnegar R
    Biochem Biophys Res Commun; 2000 Jun; 272(3):882-6. PubMed ID: 10860846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-occupancy of the interferon regulatory element of the class II transactivator (CIITA) type IV promoter by interferon regulatory factors 1 and 2.
    Xi H; Eason DD; Ghosh D; Dovhey S; Wright KL; Blanck G
    Oncogene; 1999 Oct; 18(43):5889-903. PubMed ID: 10557076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of a cell-cycle-regulated histone gene by the oncogenic transcription factor IRF-2.
    Vaughan PS; Aziz F; van Wijnen AJ; Wu S; Harada H; Taniguchi T; Soprano KJ; Stein JL; Stein GS
    Nature; 1995 Sep; 377(6547):362-5. PubMed ID: 7566094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repression of IRF-4 target genes in human T cell leukemia virus-1 infection.
    Mamane Y; Grandvaux N; Hernandez E; Sharma S; Innocente SA; Lee JM; Azimi N; Lin R; Hiscott J
    Oncogene; 2002 Oct; 21(44):6751-65. PubMed ID: 12360402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular characterization of celtix-1, a bromodomain protein interacting with the transcription factor interferon regulatory factor 2.
    Staal A; Enserink JM; Stein JL; Stein GS; van Wijnen AJ
    J Cell Physiol; 2000 Nov; 185(2):269-79. PubMed ID: 11025449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired class II transactivator expression in mice lacking interferon regulatory factor-2.
    Xi H; Goodwin B; Shepherd AT; Blanck G
    Oncogene; 2001 Jul; 20(31):4219-27. PubMed ID: 11464288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon regulatory factor 1 (IRF-1) and IRF-2 distinctively up-regulate gene expression and production of interleukin-7 in human intestinal epithelial cells.
    Oshima S; Nakamura T; Namiki S; Okada E; Tsuchiya K; Okamoto R; Yamazaki M; Yokota T; Aida M; Yamaguchi Y; Kanai T; Handa H; Watanabe M
    Mol Cell Biol; 2004 Jul; 24(14):6298-310. PubMed ID: 15226432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of genes involved in innate responsiveness to bacterial products by differential display.
    Jin F; Nathan C; Ding A
    Methods; 1998 Dec; 16(4):396-406. PubMed ID: 10049647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Involvement of positive (IRF-1) and negative (IRF-2) transcription factors in the gene regulation of the type I interferon system].
    Watanabe N; Taniguchi T
    Tanpakushitsu Kakusan Koso; 1992 Oct; 37(14 Suppl):2813-22. PubMed ID: 1438857
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.